Literature DB >> 7690292

Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin.

M Morishita1, I Morishita, K Takayama, Y Machida, T Nagai.   

Abstract

In order to determine an advantageous site for intestinal insulin absorption, the hypoglycemic effects of insulin after administration to the duodenum, the jejunum, the ileum and the colon were investigated using an in situ loop method. Insulin solution was administered to the various loops of fasted rats with or without aprotinin (AP) as a protease inhibitor, or absorption enhancers such as sodium caprate, Na2EDTA or sodium glycocholate. An obvious hypoglycemic effect of insulin alone was seen only in the ileum loop washed with phosphate buffered saline. When coadministered with AP, the most remarkably amplified effect was again observed in the ileum. In the ileum, the area under the serum insulin levels vs. time curve from 0 to 4 h was linearly related to the logarithm of the AP dose. Both sodium caprate and Na2EDTA significantly promoted the hypoglycemic effect of insulin at all sites, and their intensity increased towards the distal regions of the intestine. On the other hand, sodium glycocholate improved only colonic insulin efficacy. These results suggest that the ileum seems to be the most useful region in the small intestine for insulin absorption; however, insulin must be protected from proteolysis to enhance its absorption. In addition, the insulin efficacy could be increased by absorption promoters more effectively in the colon than in the small intestine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690292     DOI: 10.1248/bpb.16.68

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  14 in total

1.  Region-dependent role of the mucous/glycocalyx layers in insulin permeation across rat small intestinal membrane.

Authors:  Yoshinobu Aoki; Mariko Morishita; Kazunori Asai; Bunshiro Akikusa; Shuji Hosoda; Kozo Takayama
Journal:  Pharm Res       Date:  2005-07-29       Impact factor: 4.200

2.  Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer.

Authors:  Nikhil J Kavimandan; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2007-12-23       Impact factor: 5.875

3.  Design and in vivo evaluation of an oral delivery system for insulin.

Authors:  M K Marschütz; P Caliceti; A Bernkop-Schnürch
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

4.  Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats.

Authors:  A Yamamoto; T Taniguchi; K Rikyuu; T Tsuji; T Fujita; M Murakami; S Muranishi
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

5.  Novel mucosal insulin delivery systems based on fusogenic liposomes.

Authors:  Takahiro Goto; Mariko Morishita; Ken Nishimura; Mahito Nakanishi; Atsushi Kato; Jumpei Ehara; Kozo Takayama
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

6.  Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats.

Authors:  Keizo Fukushima; Ayaka Ise; Hiromi Morita; Ryo Hasegawa; Yukako Ito; Nobuyuki Sugioka; Kanji Takada
Journal:  Pharm Res       Date:  2010-03-19       Impact factor: 4.200

7.  Alginate/chitosan nanoparticles are effective for oral insulin delivery.

Authors:  B Sarmento; A Ribeiro; F Veiga; P Sampaio; R Neufeld; D Ferreira
Journal:  Pharm Res       Date:  2007-06-19       Impact factor: 4.200

8.  In vitro evaluation of polymerized liposomes as an oral drug delivery system.

Authors:  J Okada; S Cohen; R Langer
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

9.  Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.

Authors:  El-Sayed Khafagy; Ruisha Iwamae; Noriyasu Kamei; Mariko Takeda-Morishita
Journal:  AAPS J       Date:  2015-07-28       Impact factor: 4.009

Review 10.  Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.

Authors:  Yeonhee Yun; Yong Woo Cho; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.